|
C11ORF95 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.210300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.936000E-01 |
| Normal-vs-Stage2 |
2.208000E-02 |
| Normal-vs-Stage3 |
2.89399999997553E-06 |
| Normal-vs-Stage4 |
1.6089599999991E-05 |
| Stage1-vs-Stage2 |
1.371690E-02 |
| Stage1-vs-Stage3 |
1.47960000029812E-07 |
| Stage1-vs-Stage4 |
5.44499999977077E-07 |
| Stage2-vs-Stage3 |
4.800800E-01 |
| Stage2-vs-Stage4 |
3.013000E-01 |
| Stage3-vs-Stage4 |
6.331800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.616100E-03 |
| Normal-vs-AfricanAmerican |
3.577800E-01 |
| Normal-vs-Asian |
7.213200E-01 |
| Caucasian-vs-AfricanAmerican |
2.998400E-02 |
| Caucasian-vs-Asian |
4.387400E-01 |
| AfricanAmerican-vs-Asian |
9.725800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.061100E-03 |
| Normal-vs-Female |
4.022400E-01 |
| Male-vs-Female |
9.041800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.569600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.261600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.843500E-04 |
| Normal-vs-Age(81-100Yrs) |
7.675000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.675400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.316400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.879800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.040500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.166100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.949400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.443300E-03 |
| Normal-vs-Grade 2 |
3.519600E-01 |
| Normal-vs-Grade 3 |
8.20379999488807E-08 |
| Normal-vs-Grade 4 |
7.99450000000812E-05 |
| Grade 1-vs-Grade 2 |
4.612200E-02 |
| Grade 1-vs-Grade 3 |
1.11639999467172E-08 |
| Grade 1-vs-Grade 4 |
1.56129999995258E-06 |
| Grade 2-vs-Grade 3 |
2.54340004612885E-09 |
| Grade 2-vs-Grade 4 |
3.47259999999849E-06 |
| Grade 3-vs-Grade 4 |
9.176800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.460800E-01 |
| Normal-vs-ccB subtype |
1.338610E-03 |
| ccA subtype-vs-ccB subtype |
4.195100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.236500E-04 |
| Normal-vs-N1 |
4.795200E-04 |
| N0-vs-N1 |
2.046600E-01 |
|
|
